AAPS PharmSciTech

, 10:1263 | Cite as

Surfactant-free Formulation of Poly(Lactic/Glycolic) Acid Nanoparticles Encapsulating Functional Polypeptide: A Technical Note

  • Yu-Chao Wang
  • Yi-Ting Wu
  • Hsin-Ying Huang
  • Chung-Shi Yang
Brief/Technical Note

Key words

nanoparticles nerve growth factor (NGF) poly(lactic/glycolic) acid (PLGA) protein delivery surfactant-free 



This research was supported by an intramural grant from the National Health Research Institutes (NHRI-94-NM-PP-05), Taiwan.


  1. 1.
    Bilati U, Allemann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm. 2005;59:375–88.CrossRefPubMedGoogle Scholar
  2. 2.
    Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactide-co-glycolide) and its derivatives. J Control Release. 2008;125:193–209.CrossRefPubMedGoogle Scholar
  3. 3.
    Giteau A, Venier-Julienne MC, Aubert-Pouessel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm. 2008;350:14–26.CrossRefPubMedGoogle Scholar
  4. 4.
    van de Weert M, Hoechstetter J, Hennink WE, Crommelin DJ. The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release. 2000;68:351–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Nair B. Final report on the safety assessment of polyvinyl alcohol. Int J Toxicol. 1998;17:67–92.CrossRefGoogle Scholar
  6. 6.
    DeMerlis CC, Schoneker DR. Review of the oral toxicity of polyvinyl alcohol (PVA). Food Chem Toxicol. 2003;41:319–26.CrossRefPubMedGoogle Scholar
  7. 7.
    Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D, L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res. 2003;20:212–20.CrossRefPubMedGoogle Scholar
  8. 8.
    Dalwadi G, Sunderland VB. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev Ind Pharm. 2007;33:1030–9.CrossRefPubMedGoogle Scholar
  9. 9.
    Castellanos IJ, Crespo R, Griebenow K. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J Control Release. 2003;88:135–45.CrossRefPubMedGoogle Scholar
  10. 10.
    Nehilla BJ, Bergkvist M, Popat KC, Desai TA. Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int J Pharm. 2008;348:107–14.CrossRefPubMedGoogle Scholar
  11. 11.
    Kang F, Jiang G, Hinderliter A, DeLuca PP, Singh J. Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients. Pharm Res. 2002;19:629–33.CrossRefPubMedGoogle Scholar
  12. 12.
    Jeong YI, Shim YH, Kim C, Lim GT, Choi KC, Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(D, L-lactide-co-glycolide). J Microencapsul. 2005;22:593–601.CrossRefPubMedGoogle Scholar
  13. 13.
    Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release. 2002;82:105–14.CrossRefPubMedGoogle Scholar
  14. 14.
    Khan AY, Talegaonkar S, Iqbal Z, Ahmed FJ, Khar RK. Multiple emulsions: an overview. Curr Drug Deliv. 2006;3:429–43.CrossRefPubMedGoogle Scholar
  15. 15.
    Cao X, Schoichet MS. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials. 1999;20:329–39.CrossRefPubMedGoogle Scholar
  16. 16.
    Wang YC, Wu YT, Huang HY, Lin HI, Lo LW, Tzeng SF, et al. Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury. Biomaterials. 2008;29:4546–53.CrossRefPubMedGoogle Scholar
  17. 17.
    Hadlock TA, Sheahan T, Cheney ML, Vacanti JP, Sundback CA. Biologic activity of nerve growth factor slowly released from microspheres. J Reconstr Microsurg. 2003;19:179–86.CrossRefPubMedGoogle Scholar
  18. 18.
    Pean JM, Venier-Julienne MC, Filmon R, Sergent M, Phan-Tan-Luu R, Benoit JP. Optimization of HSA and NGF encapsulation yields in PLGA microparticles. Int J Pharm. 1998;166:105–15.CrossRefGoogle Scholar
  19. 19.
    Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res. 1996;13:1838–45.CrossRefPubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2009

Authors and Affiliations

  • Yu-Chao Wang
    • 1
  • Yi-Ting Wu
    • 1
  • Hsin-Ying Huang
    • 1
  • Chung-Shi Yang
    • 1
    • 2
  1. 1.Center for Nanomedicine ResearchNational Health Research InstitutesZhunanTaiwan
  2. 2.Department of Applied Chemistry and Graduate Institute of Biomedicine and Biomedical TechnologyNational Chi-Nan UniversityPuliTaiwan

Personalised recommendations